Related references
Note: Only part of the references are listed.The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer
Michela Pasello et al.
SEMINARS IN CANCER BIOLOGY (2020)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1
Dong Jun Park et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM-/CD133- nonStem Cells into EpCAM+/CD133+ Liver Cancer Stem Cells in HCC Cell Line HuH7
Zeynep Firtina Karagonlar et al.
CELLS (2020)
A Novel CD133-and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells
Zihua Wang et al.
FRONTIERS IN CHEMISTRY (2020)
Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines
Hwajung Kim et al.
BIOMEDICAL REPORTS (2020)
Mitotic quiescence in hepatic cancer stem cells: An incognito mode
Kandasamy Ashokachakkaravarthy et al.
ONCOLOGY REVIEWS (2020)
ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
Maria Paula Ceballos et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
Yu Toyoda et al.
FRONTIERS IN PHARMACOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Functional consequences of enhanced expression of STIM1 and Orai1 in Huh-7 hepatocellular carcinoma tumor-initiating cells
B. Karacicek et al.
BMC CANCER (2019)
Antiproliferative activity of (R)-4′-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition
Murat Delman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells
Yue Zhou et al.
CELL DEATH & DISEASE (2019)
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Caner Saygin et al.
CELL STEM CELL (2019)
Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway
Regina Cheuk-Lam Lo et al.
CELL DEATH AND DIFFERENTIATION (2018)
HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma
Xinying Zhao et al.
CELL DEATH & DISEASE (2018)
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle et al.
NATURE REVIEWS CANCER (2018)
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials
Antonio Facciorusso et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
The evolving concept of liver cancer stem cells
Kouki Nio et al.
MOLECULAR CANCER (2017)
Lessons Learned from Two Decades of Anticancer Drugs
Zhichao Liu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma
Chao Wang et al.
CELL DEATH & DISEASE (2017)
Effect of adipocyte-secreted factors on EpCAM+/CD133+hepatic stem cell population
Zeynep Firtina Karagonlar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence
Yan Li et al.
BMC CANCER (2016)
MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
Chenwei Pan et al.
PLOS ONE (2016)
Mechanisms of doxorubicin resistance in hepatocellular carcinoma
Josiah Cox et al.
HEPATIC ONCOLOGY (2016)
Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway
Xiao-Li Zhang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Monica Cojoc et al.
SEMINARS IN CANCER BIOLOGY (2015)
Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell
Ioannis Karakasiliotis et al.
FRONTIERS IN PHYSIOLOGY (2015)
The Inhibitor Ko143 Is Not Specific for ABCG2
Lora D. Weidner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
Ngoc Bich Vu et al.
CYTOTECHNOLOGY (2013)
Label-retaining liver cancer cells are relatively resistant to sorafenib
Hong-Wu Xin et al.
GUT (2013)
Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma
Guang Zhang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside
Omar Abdel-Rahman
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2013)
Investigational ABC transporter inhibitors
Marco Falasca et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase
Kaustubh N. Bhinge et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells
Yi Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
Satoshi Shimizu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
Cord Naujokat et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
Katia Meirelles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Terence Kin Wah Lee et al.
CELL STEM CELL (2011)
Granulin-Epithelin Precursor and ATP-Dependent Binding Cassette (ABC)B5 Regulate Liver Cancer Cell Chemoresistance
Siu Tim Cheung et al.
GASTROENTEROLOGY (2011)
Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations
Xiaoli Chen et al.
JOURNAL OF HEPATOLOGY (2011)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
P21-activated protein kinase 1 induces colorectal cancer metastasis involving ERK activation and phosphorylation of FAK at Ser-910
Liang-Hui Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
Benoit Terris et al.
JOURNAL OF HEPATOLOGY (2010)
Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies
Zhengang Sun et al.
TUMORI JOURNAL (2010)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Expansion of CD133-Expressing Liver Cancer Stem Cells in Liver-Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10-Deleted Mice
C. Bart Rountree et al.
STEM CELLS (2009)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin
Sara Vander Borght et al.
LIVER INTERNATIONAL (2008)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Shengyong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
Marcia Munoz et al.
IUBMB LIFE (2007)
A high-throughput cell-based assay for inhibitors of ABCG2 activity
CJ Henrich et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection
A Kato et al.
JOURNAL OF SURGICAL ONCOLOGY (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
Expression of P-glycoprotein in hepatocellular carcinoma - A determinant of chemotherapy response
IOL Ng et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
